MakeMyTrip Files Confidential IPO Papers With Sebi For Listing Of Indian Subsidiary
MakeMyTrip has confidentially filed DRHP papers with Sebi for the proposed IPO of its Indian subsidiary, MakeMyTrip India Ltd. The offer is expected to comprise a sale of shares by the parent company and ibibo Group Holdings, with the proceeds intended to support long-term growth, strategic initiatives and capital management.
MakeMyTrip has confidentially filed IPO papers with Sebi for the proposed listing of its Indian subsidiary | AI Generated Representational Image
New Delhi, July 17, 2026: NASDAQ-listed travel booking platform MakeMyTrip on Friday said it has confidentially filed draft red herring prospectus (DRHP) papers with capital markets regulator Sebi for the proposed initial public offering (IPO) of its Indian subsidiary.
The company said its wholly owned subsidiary, MakeMyTrip (India) Ltd (MMT India), has submitted the confidential filing with the Securities and Exchange Board of India (Sebi), BSE and the National Stock Exchange (NSE) for listing on the main board of the stock exchanges.
IPO Filing Submitted
The proposed IPO is expected to involve the sale of equity shares in MMT India by MakeMyTrip and its wholly owned subsidiary, ibibo Group Holdings (Singapore) Pte Ltd, the Gurugram-headquartered firm said in a regulatory filing with NASDAQ.
Following completion of the proposed IPO, MMT India will continue to remain a subsidiary of MakeMyTrip and its financial results will continue to be consolidated with those of the parent company, it said.
"MakeMyTrip expects the proposed initial public offering and listing of MMT India to enhance its brand visibility and support MMT India's ability to incentivise and promote talent in a competitive technology recruitment landscape," the filing stated.
Growth And Expansion Plans
Net proceeds received by MakeMyTrip and ibibo Holdings from the sale of shares in MMT India will further strengthen the cash position of MakeMyTrip and are expected to be utilised for long-term growth, strategic inorganic initiatives and repurchases of different classes of securities (including convertible securities) by MakeMyTrip, the company said in the filing.
Also Watch:
Subject to regulatory approvals, MakeMyTrip and MMT India may evaluate alternatives in the medium term to enable their respective shareholders to enjoy the benefits of a security at the MMT India level that is fungible and listed across the Indian and US capital markets, the company said.
(Disclaimer: Except for the headline, this article has not been edited by FPJ's editorial team and is auto-generated from an agency feed.)
RECENT STORIES
-
-
-
-
-